Evidence map›Paper›PMID 30506103›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma.

Lahiru Russell, Anna Ugalde, Liliana Orellana, Donna Milne, Meinir Krishnasamy, Richard Chambers, David W Austin, Patricia M Livingston

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 10 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 10 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Survivorship care for melanoma patients: a scoping review.Journal of cancer survivorship : research and practice · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lahiru RussellSchool of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, Victoria, Australia. l.russell@deakin.edu.au.ORCID http://orcid.org/0000-0002-3806-0020
Anna UgaldeSchool of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Liliana OrellanaBiostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia.
Donna MilneSkin and Melanoma Services/Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Meinir KrishnasamyDepartment of Nursing, School of Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Richard ChambersCampus Community Division, Monash University, 40 Exhibition Walk, Clayton, Victoria, 3800, Australia.
David W AustinSchool of Psychology, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Patricia M LivingstonSchool of Nursing and Midwifery, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Deakin University · AUMonash University · AUPeter MacCallum Cancer Centre · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study assessed the feasibility and acceptability of an online mindfulness-based intervention (MBI) for people diagnosed with melanoma. The potential benefit of the MBI on fear of cancer recurrence (FCR), worry, rumination, perceived stress and trait mindfulness was also explored.

methodsParticipants who have completed treatment for stage 2c or 3 melanoma were recruited from an outpatient clinic and randomly allocated to either the online MBI (intervention) or usual care (control). The 6-week online MBI comprised short videos, daily guided meditations and automated email reminders. Participants were asked to complete questionnaires at baseline and at 6-week post-randomisation. Study feasibility and acceptability were assessed through recruitment rates, retention and participant feedback. Clinical and psychosocial outcomes were compared between groups using linear mixed models.

resultsSixty-nine (58%) eligible participants were randomised (46 in the intervention; 23 in the control group); mean age was 53.4 (SD 13.1); 54% were female. Study completion rate across both arms was 80%. The intervention was found helpful by 72% of the 32 respondents. The intervention significantly reduced the severity of FCR compared to the control group (mean difference = - 2.55; 95% CI - 4.43, - 0.67; p = 0.008). There was no difference between the intervention and control groups on any of the outcome measures.

conclusionsThis online MBI was feasible and acceptable by people at high risk of melanoma recurrence. It significantly reduced FCR severity in this sample. Patients valued accessing the program at their own pace and convenience. This self-guided intervention has the potential to help survivors cope with emotional difficulties. An adequately powered randomised controlled trial to test study findings is warranted.

Indexed as

Adaptation, PsychologicalAnxietyCancer SurvivorsFeasibility StudiesFemaleHumansInternetMaleMelanomaMiddle AgedMindfulnessNeoplasm Recurrence, LocalOutcome Assessment, Health CarePilot ProjectsSkin NeoplasmsSurveys and QuestionnairesCancerFearFeasibilityMelanomaMindfulnessOncologyOnline

Identifiers

PMID30506103
OpenAlexW2903528417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.